Realizing the gains and losses in C9ORF72 ALS/FTD

At the heart of C9ORF72-related amyotrophic lateral sclerosis and frontotemporal dementia (ALS /FTD) research lies the mechanistic question of whether disease is caused by toxic gain of function related to the repeat expansion, loss of endogenous C9ORF72 expression, or both. New findings provide insights to this question.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: C9orf72 pathology may be a synergy of loss- and gain-of-function mechanisms.


  1. 1.

    DeJesus-Hernandez, M. et al. Neuron 72, 245–256 (2011).

    CAS  Article  Google Scholar 

  2. 2.

    Jiang, J. et al. Neuron 90, 535–550 (2016).

    CAS  Article  Google Scholar 

  3. 3.

    Zhu, Q. et al. Nat. Neurosci. (2020).

    Article  PubMed  Google Scholar 

  4. 4.

    Ash, P. E. et al. Neuron 77, 639–646 (2013).

    CAS  Article  Google Scholar 

  5. 5.

    Gijselinck, I. et al. Lancet Neurol. 11, 54–65 (2012).

    CAS  Article  Google Scholar 

  6. 6.

    Therrien, M., Rouleau, G. A., Dion, P. A. & Parker, J. A. PLoS One 8, e83450 (2013).

    Article  Google Scholar 

  7. 7.

    Ciura, S. et al. Ann. Neurol. 74, 180–187 (2013).

    CAS  PubMed  Google Scholar 

  8. 8.

    O’Rourke, J. G. et al. Science 351, 1324–1329 (2016).

    Article  Google Scholar 

  9. 9.

    Burberry, A. et al. Sci. Transl. Med. 8, 347ra93 (2016).

    Article  Google Scholar 

  10. 10.

    Chew, J. et al. Science 348, 1151–1154 (2015).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Cathleen Lutz.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lutz, C. Realizing the gains and losses in C9ORF72 ALS/FTD. Nat Neurosci 23, 596–597 (2020).

Download citation


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing